Inabata & (8098) FY2027 Q1 Earnings Report

Quick View

Executive Summary

FY2027 Q1 delivered increases in both revenue and profit, with the results characterized by improved profitability driven by operating leverage. Revenue was ¥2436.6B (+19.4% YoY), Operating Income was ¥98.3B (+48.8%), Ordinary Income was ¥101.7B (+38.0%), and Net Income was ¥68.4B (+9.1%). The primary reasons Operating Income increased significantly faster than revenue were an improvement in the gross profit margin and the containment of SG&A expenses. Meanwhile, the relatively modest growth in Net Income was attributable to the reversal of special gains and losses, including the absence of gains on the sale of investment securities recorded in the same period of the previous year and the recognition of valuation losses on investment securities in the current period.

Factors Affecting Performance

【Revenue】Revenue increased 19.4% YoY to ¥2436.6B. By segment, Synthetic Resins, the core business, led company-wide growth with revenue of ¥1245.2B (51.1% of total revenue, +25.3% YoY), while Chemicals at ¥364.2B (+21.4%), Life Science & Industry at ¥167.4B (+15.9%), and Information & Electronics at ¥659.2B (+9.5%) all posted revenue growth.

【Profit and Loss】Operating Income increased 48.8% YoY to ¥98.3B, expanding at a pace that exceeded revenue growth. The gross profit margin improved to 10.3% from approximately 9.9% in the same period of the previous year, while SG&A expense growth (+11.0%) remained below revenue growth (+19.4%). Consequently, the Operating Income margin expanded to 4.0% from 3.2%. Ordinary Income was ¥101.7B (+38.0%), while Net Income was limited to ¥68.4B (+9.1%). This was due to the reversal of temporary factors: gains on the sale of investment securities of ¥11.4B were recorded in the same period of the previous year, whereas valuation losses on investment securities of ¥4.3B were recorded as extraordinary losses in the current period. In conclusion, the company achieved increases in both revenue and profit, with the quality of profit growth centered on structural improvements at the operating level.

Segment Analysis

Synthetic Resins recorded revenue of ¥1245.2B (+25.3% YoY) and segment profit of ¥54.3B (+65.1%), making it the largest source of profit and accounting for 55.4% of total segment profit. Chemicals recorded revenue of ¥364.2B (+21.4%) and profit of ¥13.7B (+76.3%), representing the highest rate of profit growth. Life Science & Industry recorded revenue of ¥167.4B (+15.9%) and profit of ¥8.2B (+49.2%). Information & Electronics recorded revenue of ¥659.2B (+9.5%) and profit of ¥21.8B (+11.5%); its profit growth was moderate relative to the other divisions, and its profit margin was also comparatively low at 3.3%. Against a backdrop of revenue and profit growth across all segments, margin improvements in Synthetic Resins and Chemicals led company-wide operating leverage.

Key Financial Indicators

【Profitability】The Operating Income margin was 4.0%, improving by +0.8pt from 3.2% in the same period of the previous year, while the gross profit margin also expanded to 10.3%. The Net Income margin was 2.8%, slightly lower than the previous year due to the reversal of special gains and losses.【Cash Flow Quality】The divergence between Ordinary Income and Net Income was attributable to the temporary factor of ¥4.3B in valuation losses on investment securities, while underlying profit growth based on operating activities remained solid.【Investment Efficiency】ROE (annualized) was 10.8%, indicating a business structure in which high asset turnover compensates for low margins.【Financial Soundness】The Equity Ratio remained stable at 47.8% (47.3% in the previous year), while current assets of ¥422.15B substantially exceeded current liabilities of ¥207.81B. However, short-term borrowings increased to ¥47.46B (+27.9% YoY), and trends in short-term financing associated with the expansion of working capital warrant monitoring.

Cash Flow Analysis

As the financial results do not include disclosure of a cash flow statement, funding trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥67.90B, down from ¥76.84B in the same period of the previous year, while accounts receivable and notes receivable increased to ¥199.32B (¥179.47B in the previous year) and inventories increased to ¥100.96B (¥89.10B in the previous year). This indicates that working capital has been built up in line with revenue expansion. The company appears to have financed this working capital requirement primarily through an increase in short-term borrowings (+27.9% YoY, ¥47.46B). From the perspective of funding efficiency, the management of accounts receivable collections and inventory turnover will determine the stability of future liquidity.

Quality of Earnings

Current-period Profit Before Tax of ¥97.4B increased 14.4% YoY, below the growth rates of Operating Income (+48.8%) and Ordinary Income (+38.0%); this difference was attributable to fluctuations in special gains and losses. The same period of the previous year included a temporary boost from gains on the sale of investment securities of ¥11.4B. This gain was absent in the current period, which instead included valuation losses on investment securities of ¥4.3B. Of ¥9.5B in non-operating income, dividends received of ¥3.4B and interest received of ¥2.6B were the main components, representing a stable earnings composition linked to the business. Comprehensive Income was ¥98.0B (+107.7% YoY), exceeding Net Income of ¥68.4B. The difference was primarily due to an increase of ¥25.5B in foreign currency translation adjustments, indicating a greater improvement in financial strength than suggested by Net Income growth alone. Profit growth from recurring operating activities remained solid, and the sluggish growth in Net Income can primarily be attributed to temporary factors related to securities.

Earnings Forecast and Guidance

The full-year plan calls for revenue of ¥890.0B (+6.9% YoY), Operating Income of ¥27.50B (+5.1%), and Ordinary Income of ¥27.50B (-0.9%). As of Q1, the company had not revised its forecasts. Progress rates were 27.4% for revenue, 35.8% for Operating Income, and 37.0% for Ordinary Income, all exceeding the 25% benchmark based on simple linear progress. Although progress in Operating Income and Ordinary Income is ahead of schedule, second-half performance may fluctuate depending on market conditions and spreads for Synthetic Resins and Chemicals.

Shareholder Returns

The full-year dividend forecast is ¥143.00 per share, implying a Payout Ratio of approximately 36.4% based on projected full-year EPS of ¥393.39. As the dividend for the same period of the previous year was ¥63, the full-year plan indicates an increase in dividends. The dividend forecast was not revised during the quarter. With retained earnings of ¥167.47B, the company has sufficient capacity to fund dividends.

Risk Factors

1. Market volatility risk in the core business: Synthetic Resins accounts for 55.4% of total segment profit, creating a structure in which fluctuations in raw material prices and sales spreads can have a significant impact on company-wide profit.

2. Dependence on short-term financing: Short-term borrowings increased to ¥47.46B, up +27.9% YoY, and dependence on short-term borrowing is rising in line with the expansion of working capital (accounts receivable of ¥199.32B and inventories of ¥100.96B).

3. Valuation fluctuations in investment securities: The company recorded valuation losses on investment securities of ¥4.3B in the current period, and price fluctuations in its investment securities holdings of ¥43.96B may continue to affect Net Income and Comprehensive Income.

Industry Benchmark (For Reference; Company Analysis)

Profitability and Returns

The profitability metrics are slightly below the industry median.

Growth and Capital Efficiency

The revenue growth rate substantially exceeds the industry median, placing the company among the high-growth companies in the industry.

※Source: Company analysis

Key Takeaways from the Results

1. Against revenue growth of +19.4%, Operating Income increased +48.8%, indicating that operating leverage driven by an improvement in the gross profit margin (+approximately 0.4pt) and the containment of SG&A expense growth (+11.0%) was the main feature of Q1.

2. Net Income growth (+9.1%) was below the growth rates of Operating Income and Ordinary Income. This was attributable to special gains and losses, specifically the absence of gains on the sale of investment securities recorded in the previous year and the recognition of valuation losses in the current period. It should therefore be viewed separately from profit growth at the operating level.

3. Progress rates for Operating Income and Ordinary Income against the full-year plan both exceeded the standard 25% benchmark. However, the company has maintained its forecasts unchanged, and trends in Synthetic Resins and Chemicals spreads during the second half will be key to achieving the plan.

Theoretical Share Price (Reference Value)

Sensitivity: ¥4,446–¥4,704 for a ±1% change in the Cost of Equity, and ¥4,567–¥4,576 for a change of ±0.1 in ω.

Notes:

• As forecast ROE is below the Cost of Equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used; therefore, there is a timing difference from the full-year forecast.
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data. It does not constitute a forecast of the market share price or a recommendation of any specific investment action, nor does it predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional as necessary.

---End of Report---